ROYAL BANK OF CANADA - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 108 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$24,000
+84.6%
7,257
+128.9%
0.00%
Q1 2024$13,000
-85.7%
3,170
-89.3%
0.00%
Q4 2023$91,000
+116.7%
29,609
+111.1%
0.00%
Q3 2023$42,000
+40.0%
14,024
+75.3%
0.00%
Q2 2023$30,000
+57.9%
7,998
+38.5%
0.00%
Q1 2023$19,000
-63.5%
5,774
-45.9%
0.00%
Q4 2022$52,000
+100.0%
10,664
+135.1%
0.00%
Q3 2022$26,000
+73.3%
4,536
+123.6%
0.00%
Q2 2022$15,000
-63.4%
2,029
-63.6%
0.00%
Q1 2022$41,000
-59.0%
5,568
-50.5%
0.00%
Q4 2021$100,000
-65.5%
11,249
+36.4%
0.00%
Q3 2021$290,000
+118.0%
8,247
+33.9%
0.00%
Q2 2021$133,000
+121.7%
6,157
+530.2%
0.00%
Q1 2021$60,000
+300.0%
977
+169.9%
0.00%
Q4 2020$15,0003620.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 5,462,079$16,659,34112.62%
TANG CAPITAL MANAGEMENT LLC 4,076,741$12,434,0601.15%
Stonepine Capital Management, LLC 839,514$2,560,5181.11%
Bain Capital Life Sciences Investors, LLC 2,485,638$7,581,1960.73%
CM Management, LLC 270,000$823,5000.66%
EcoR1 Capital, LLC 6,995,861$21,337,3760.55%
Acuitas Investments, LLC 171,098$615,3730.32%
Newtyn Management, LLC 508,474$1,550,8460.30%
Diametric Capital, LP 161,524$492,6480.30%
Auour Investments LLC 177,000$670,8300.26%
View complete list of ATEA PHARMACEUTICALS INC shareholders